HanchorBio Inc. (TPE:7827)
Taiwan · Delayed Price · Currency is TWD 156.50
+0.50 (0.32%)
At close: Aug 6, 2026
HanchorBio Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -512.93 | -276.72 | -1,354 | -591.36 | -446.32 |
Depreciation & Amortization | 36.82 | 36.71 | 36.28 | 33.04 | 26.12 |
Other Amortization | 1.25 | 1.18 | 1.12 | 0.84 | 0.75 |
Loss (Gain) From Sale of Investments | - | - | -1.12 | -0.94 | -1.13 |
Stock-Based Compensation | 21.86 | 9.94 | 311.96 | 47.9 | 37.33 |
Other Operating Activities | -104.19 | -111.85 | 399.21 | 62.51 | -81.63 |
Change in Accounts Receivable | -0.43 | -1.59 | -1.31 | 0.05 | 2.29 |
Change in Accounts Payable | 26.18 | 26.18 | 1.72 | 14.52 | 124.77 |
Change in Other Net Operating Assets | 93.73 | -2.27 | -1.44 | -6.15 | 0.22 |
Operating Cash Flow | -437.71 | -318.42 | -607.67 | -439.59 | -337.62 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | -18.25 | -17.16 | -18.78 | -22.04 | -70.78 |
Sale (Purchase) of Intangibles | -1.58 | -1.58 | -0.19 | -1.14 | - |
Investment in Securities | -46.26 | 13.95 | 76.36 | -87.71 | 1.13 |
Other Investing Activities | -1.47 | -0.39 | 0.91 | - | - |
Investing Cash Flow | -67.56 | -5.18 | 58.31 | -110.9 | -69.65 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Short-Term Debt Issued | - | 122.53 | 26.24 | 29.69 | - |
Long-Term Debt Issued | - | - | - | - | 20 |
Total Debt Issued | 136.63 | 122.53 | 26.24 | 29.69 | 20 |
Short-Term Debt Repaid | - | -55.86 | -30.47 | - | - |
Long-Term Debt Repaid | - | -12.32 | -20.1 | -20.07 | -11.39 |
Total Debt Repaid | -101.02 | -68.18 | -50.57 | -20.07 | -11.39 |
Net Debt Issued (Repaid) | 35.61 | 54.35 | -24.33 | 9.62 | 8.61 |
Issuance of Common Stock | 701.81 | 685.41 | 120.08 | - | - |
Repurchase of Common Stock | -0.07 | -0.07 | - | - | - |
Other Financing Activities | 211.71 | 211.71 | 509.22 | 635.6 | 491.09 |
Financing Cash Flow | 949.06 | 951.39 | 604.98 | 645.22 | 499.7 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Foreign Exchange Rate Adjustments | 43.23 | 31.11 | 8.02 | 1.05 | 12.53 |
Net Cash Flow | 487.02 | 658.9 | 63.63 | 95.78 | 104.97 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -455.96 | -335.58 | -626.45 | -461.63 | -408.39 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -146.04% | -107.48% | - | - | -12143.74% |
Free Cash Flow Per Share | -3.64 | -2.74 | -9.42 | -8.87 | -9.23 |
Levered Free Cash Flow | - | -255.5 | -179.45 | -296.65 | - |
Unlevered Free Cash Flow | - | -253.67 | -176.39 | -294.92 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash Interest Paid | 3.1 | 2.93 | 4.9 | 2.74 | 2.5 |
Cash Income Tax Paid | 22.58 | 22.58 | - | - | - |
Change in Working Capital | 119.48 | 22.32 | -1.03 | 8.42 | 127.28 |